Skúšobnú verziu novej webovej stránky nájdete na beta.sukl.sk. Všetky aktuality, informácie a kompletný obsah sú zatiaľ prioritne dostupné na pôvodnej verzii webu.
en

SIDC Guidance on the Processing of Type IA and IB Notifications

SIDC Guidance on the Processing of Type IA and IB Notifications

Information for Marketing Authorisation Holders

To ensure a full compliance with the valid legislation the State Institute for Drug Control changes the Guidance for  processing of type IA and IB variations from 1 October 2007  as follows:

 

Guidance on Type IA Notification:

An applicant submits to the State Institute:

a) 4 originals of a Notification Form (formerly 3 were required),

b) all required documents including those amended as a result of this notification.

State Institute acknowledges the receipt of notification by stamping [1] one of the Notification Forms at a submission (sending by mail is also acceptable, in this case State Institute will send a stamped Notification Form to the applicant).

If a notification is compliant with the conditions set out in the Commission Regulation [2], State Institute will make a confirmation on the validity of the notification within 14 days from the receipt by stamping [3] the Notification Form which will be forwarded to the applicant by the coordinator/assistant without any delay.

In a case of consequential revision of the marketing authorisation decision including enclosures (note: this means any update/change in SmPC, PIL and Labelling) State Institute will make a confirmation on the validity of the notification and respective enclosures will be attached.

This guidance is valid for national marketing authorisations and also for common European procedures (MRP/DCP) in a case that the Slovak Republic acts as a reference member state.

If the Slovak Republic acts in a common European procedures (MRP/DCP) as a concerned member state, State Institute will make a confirmation on validity of the notification and respective annexes will be attached only in a case of consequential revision of the marketing authorisation decision including annexes (note: this means any update/change in SmPC, PIL and Labelling.

 

Guidance on Type IB Notification:

An applicant submits to the State Institute:

a) 4 originals of a Notification Form (formerly 3 were required),

b) all required documents including those which will be changed and/or added within the notification concerned.

State Institute acknowledges the receipt of notification by stamping [1] one of the Notification Forms at a submission (sending by mail is also acceptable, in this case State Institute will send a stamped Notification Form to the applicant).

If a notification is compliant with the conditions set out in the Commission Regulation [2], State Institute will make a confirmation on the receipt of the valid notification within 5 days from the receipt by stamping [4] the notification form which will be forwarded to the applicant and the procedure shall start.

If a notification is not compliant with the conditions set out in the Commission Regulation [2], State Institute will refuse the submission without any delay and a non-acceptance grounds will be stated.

If State Institute will not sent any statement to the applicant within 30 days from the day of receipt a variation is considered as accepted.

In a case of consequential revision of the marketing authorisation decision including enclosures (note: this means any update/change in SmPC, PIL and Labelling) State Institute will make a confirmation on the receipt of the valid notification and respective annexes will be attached.

This guidance is valid for national marketing authorisations and also for common European procedures (MRP/DCP) in a case that the Slovak Republic acts as a reference member state.

If State Institute is of the opinion that a notification is not acceptable State Institute will proceed in compliance with paragraphs 8 - 11 of Article 5 EC Regulation.

 

[1] Text on stamp: Štátny ústav pre kontrolu liečiv, Kvetná 11, 825 08 Bratislava 26, dňa: dd.mm.rrrr (translation: State Institute for Drug Control, Kvetná 11, 825 08 Bratislava 26, date: dd.mm.rrrr)

[2] EC Regulation (ES) 1084/2003 of 3 June 2003 concerning the examination of variations to the terms of a marketing authorisation for medicinal products for human use and veterinary medicinal products granted by a competent authority of a Member State;

[3] Text on stamp: Štátny ústav potvrdzuje platnosť oznámenia, dňa: dd.mm.rrrr;  (translation :State Institute confirms the validity of the notification, date: dd.mm.rrrr);

[4] Text on stamp: Štátny ústav potvrdzuje doručenie platného oznámenia, dňa: dd.mm.rrrr  (translation: State Institute confirms the receipt of the valid notification, date: dd.mm.rrrr)

[5] Notice to Applicants, VOLUME 2A, Procedures for marketing authorisation, CHAPTER 5;

Act 140/1998 Z. z. on medicinal products and medical devices as amended;

Act71/1967 Z. z. on  administrative procedure as amended.

 

 

Print page
eu-flag.png sk-flag.png